PERSPECTIVE
Accepted on 18 Apr 2025
Strategies for CRISPR-based knock-ins in primary human B cells and lymphoma cell lines
doi 10.3389/fimmu.2025.1589729
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Safety and efficacy of CRISPR/Cas-based genome editing tools: applications and considerations in cell and gene therapy
Safety and efficacy of CRISPR/Cas-based genome editing tools: applications and considerations in cell and gene therapy
576
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: